Hepatitis Observatory

Polaris observatory provides the most up to date estimates for HCV, HBV and HDV disease burden and strategies that can achieve defined targets.

Read more about us

Trusted partner from data gathering to decision making

Welcome to the Polaris Observatory

The Polaris Observatory is developed and managed by the CDA Foundation, a non-profit organization. The goal of the Polaris Observatory is to provide data, tools, training and decision analytics to support elimination of hepatitis B and C globally by 2030. The activities of the observatory are overseen by an independent advisory board with representatives from global health organizations, academia, liver societies, civil societies and donors. Read more...


Diagnosis remains the primary bottleneck in achieving Global Health Sector Strategy

State, regional & global HCV disease burden analyses are now available on Polaris

Updated HBV prevalence estimates are now available on Polaris Observatory

Polaris Observatory collaborates with US CDC in Tanzania and Uzbekistan

Brazil will provide open acces to the DAAs by 2018

HCV projections and strategies in the Eastern Mediterranean Region

Progress towards faster HCV diagnosis in Cameroon

Rwanda to expand treatment and vaccine efforts as part of World Hepatitis Day Celebrations

Study planned on HIV, Hepatitis, and Syphilis in Tanzania

What happened to the prices of medicines being a barrier to treatment?

Portugal provides unrestricted access to DAAs

HCV related transplants decline in Japan

HCV prevalence much lower than initially believed in Cameroon

Hepatitis B continues to be a scourge in West African states

Qatar Ministry of Public Health offers free HCV screening

CDA collaborates with Colorado Department of Public Health & Environment to quantify HCV burden in the State

The HBV PRoGReSs model is better than before

Impact of immigration on HCV disease burden

Free training offered by the CDA Foundation

The total number of HCV patients increased to 1.7 million in 2016 but treatment declined in high income Western Countries

Romania will treat 12,000 HCV patients in 2017-2018.

Homie Razavi nominated for HCV Change Makers by the Economist Intelligence Unit.

Treatment of hepatitis C has more than doubled since 2013. Yet 99% of people are still being denied the life-saving cure

Globally, 95% of people living with a cancer-causing illness are unaware

Treatment of HCV has more than doubled since 2013, but we have a long way to go

Homie Razavi appointed to the Board of the World Hepatitis Alliance

Polaris Observatory was developed by:  
Made possible through funding from:
John Martin Foundation

Copyright © polarisobservatory.com All rights reserved